<DOC>
	<DOC>NCT02260336</DOC>
	<brief_summary>The purpose of this study is to evaluate the effect of Panax Notoginseng Powders on Rheumatic Pain.</brief_summary>
	<brief_title>The Effect of Panax Notoginseng Powders on Rheumatic Pain</brief_title>
	<detailed_description />
	<mesh_term>Rheumatic Diseases</mesh_term>
	<mesh_term>Musculoskeletal Pain</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>had a diagnosis of classic or definite RA without conflict to the written, informed consent signed prior to the enrollment. uncontrolled medical problems organic brain syndrome major psychiatric disturbances major communicative disorders a history of severe noncompliance less than 7 years of formal education, or illiteracy being included in other clinical trial within the last 4 weeks with abnormal liver or kidney function (more than 1 time above the high normal) with serious cardiovascular disease with hematologic disease being in pregnancy, lactation period or under a pregnancy plan with severe gastrointestinal disease with contraindication or being allergic to the test drugs being under the treatment of drugs within 1 previous week, that might affect the results of the trial, such as nonsteroidal antiinflammatory drugs being not compatible for the trial medication, or other circumstances at the discretion of investigators without legal capacity or only with limited legal capacity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>